Sorry, you need to enable JavaScript to visit this website.

This site is intended only for healthcare professionals resident in the United Kingdom

CNS, Pain and Inflammation

Chronic pain and inflammatory conditions can seriously impact on quality of life for patients and those caring for them. We aim to improve the well-being of patients suffering from pain or inflammatory conditions by offering treatments that target pain and inflammation at the molecular level. Our drug portfolio includes treatments for debilitating autoimmune diseases and chronic pain caused by conditions such as arthritis. 

 

Other drugs within our portfolio include

ARTHROTEC

(diclofenac sodium)

Summary of Product Characteristics

ATRACURIUM

(atracurium besilate)

Summary of Product Characteristics

DEPO MEDRONE® WITH LIDOCAINE

(methylprednisolone, lidocaine hydrochloride)

Summary of Product Characteristics

DEXAMETHASONE

(dexamethasone sodium phosphate)

Summary of Product Characteristics

KETALAR™

(ketamine hydrochloride)

Summary of Product Characteristics

LEVETIRACETAM

(levetiracetam)

Summary of Product Characteristics

MEDRONE®

(methylprednisolone)

Summary of Product Characteristics

PANCURONIUM BROMIDE

(pancuronium bromide)

Summary of Product Characteristics

PHENYTOIN

(phenytoin sodium)

Summary of Product Characteristics

PRO-EPANUTIN™

(fosphenytoin sodium)

Summary of Product Characteristics

SOLU-CORTEF®

(hydrocortisone sodium succinate)

Summary of Product Characteristics

SOLU-MEDRONE®

(methylprednisolone sodium succinate)

Summary of Product Characteristics

VESIERRA®

(esketamine hydrochloride)

Summary of Product Characteristics

ZOTON FASTAB™

(zotonfastab)

Summary of Product Characteristics
Back to top